ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,282.40
      1.44%
      Dow Jones
      40,415.44
      0.32%
      Brent Oil
      81.575
      -0.86%
      Bitcoin
      68,034.45
      -0.18%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Aelis Farma SA (AELIS) Quote

      Aelis Farma SA

      Aelis Farma SA (AELIS)

      EU
      11.80
      0.00
      (0.00%)
      Closed July 22 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      11.80
      Bid
      11.70
      Ask
      12.00
      Volume
      23
      11.80 Day's Range 11.90
      11.80 52 Week Range 13.95
      Market Cap
      156.442M
      Previous Close
      11.80
      Open
      11.90
      Last Trade
      2
      @
      11.8
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      394
      Shares Outstanding
      13,257,762
      Dividend Yield
      -
      PE Ratio
      -30.81
      Earnings Per Share (EPS)
      -0.38
      Revenue
      12.36M
      Net Profit
      -5.08M

      About Aelis Farma SA

      Sector
      Coml Physical, Biologcl Resh
      Industry
      Coml Physical, Biologcl Resh
      Website
      www.aelisfarma.com
      Headquarters
      Bordeaux, Gironde, Fra
      Founded
      1970
      Aelis Farma SA is listed in the Coml Physical, Biologcl Resh sector of the Euronext with ticker AELIS. The last closing price for Aelis Farma was 11.80 €. Over the last year, Aelis Farma shares have traded in a share price range of 11.80 € to 13.95 €.

      Aelis Farma currently has 13,257,762 shares outstanding. The market capitalization of Aelis Farma is 156.44 € million. Aelis Farma has a price to earnings ratio (PE ratio) of -30.81.

      AELIS Latest News

      More News

      Bilan semestriel du contrat de liquidité et apport complémentaire au contrat de liquidité conclu avec Invest Securities

      Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

      July 02 2024
      Business Wire

      Aelis Farma : Mise à disposition du descriptif du programme de rachat d’actions

      Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME) (Paris:AELIS), société biopharmaceutique au stade clinique spécialisée dans le développement de...

      June 24 2024
      Business Wire

      Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities

      Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

      June 13 2024
      Business Wire

      Communication des résultats de l’Assemblée générale mixte d’Aelis Farma du 4 juin 2024

      Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

      June 04 2024
      Business Wire

      Aelis Farma: Combined General Meeting of June 4, 2024: Availability of Preparatory Documents and Participation and Voting Procedures

      Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases, informs its...

      May 14 2024
      Business Wire

      Aelis Farma: Availability of the 2023 Universal Registration Document

      Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces the...

      April 25 2024
      Business Wire

      Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder

      The last patient in the clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder has completed its last medical visit, paving the way for the release of study results in...

      April 18 2024
      Business Wire

      Aelis Farma : Apport complémentaire au contrat de liquidité conclu avec Invest Securities

      Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les...

      April 05 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.2-1.66666666667121211.82711.89724771DE
      4-1-7.812512.812.911.864012.28702623DE
      12-1.3-9.9236641221413.113.311.839412.59787089DE
      26-1.65-12.267657992613.4513.611.836712.9293324DE
      52-2.1-15.107913669113.913.9511.831513.18508413DE
      156-1.7-12.592592592613.514.488.5661912.84382968DE
      260-1.7-12.592592592613.514.488.5661912.84382968DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      AAGRAfrican Agriculture Holdings Inc
      $ 0.00
      (0.00%)
      		0
      AADRAdvisorShares Dorsey Wright ADR ETF
      $ 0.00
      (0.00%)
      		0
      AADIAadi Bioscience Inc
      $ 0.00
      (0.00%)
      		0
      AACIArmada Acquisition Corporation I
      $ 0.00
      (0.00%)
      		0
      AACGATA Creativity Global
      $ 0.00
      (0.00%)
      		0
      NVDANVIDIA Corporation
      $ 123.39
      (-0.28%)
      		22.4M
      LIFWMSP Recovery Inc
      $ 0.8501
      (70.46%)
      		5.31M
      MIRAMIRA Pharmaceuticals Inc
      $ 3.94
      (-21.36%)
      		4.18M
      HRTXHeron Therapeautics Inc
      $ 3.20
      (0.00%)
      		3.01M
      LUXHLuxUrban Hotels Inc
      $ 0.169
      (14.73%)
      		2.32M

      Discussion

      View Full Feed
      Mark Mark 3 minutes ago
      $AAGR .19
      AAGR
      janetcanada janetcanada 3 minutes ago
      HIRU - It is an Exciting Stock!.....Looking forward with Much Anticipation!.....

      Thank You!

      Wishing the Very best
      janet
      HIRU
      Lazarus Elite Lazarus Elite 3 minutes ago
      Dude, just block him. We all know who he really is, and he has shown how FURIOUS he gets when he gets blocked by raging on the yahoo boards about it. Literally nothing makes him feel more impotent and it hits him right in the wallet.
      ELTP
      Acme Investments Acme Investments 3 minutes ago
      Victory just isn't fun if it's not snatched from the hands 👐 of defeat!! Yes, I created that!! Lol 😂
      BCAP
      facts_matter14 facts_matter14 3 minutes ago
      $37 in volume today?? Maxine is a Genius!!!!
      SRMX
      Viewmont Viewmont 3 minutes ago
      Wow! That's something! It looks like we have a winner here! Daily +48%. I won't complain!
      HIRU
      US-JUSTICE US-JUSTICE 3 minutes ago
      for investment scams like bioteches, you need the co operation of the SEC, FDA, and management and paid promoters like cowtown to make it work. and judges and lawyers....over 100 million was ripped off from institutionaal investors. as for retail investors they peons and were not necessary and used
      Ribo Ribo 4 minutes ago
      https://www.forbes.com/sites/digital-assets/2024/07/22/its-inevitable-bitcoin-price-suddenly-soars-on-wild-rumors-donald-trump-will-create-a-us-bitcoin-strategic-reserve/
      CGAC
      CarlCarlMcB CarlCarlMcB 4 minutes ago
      Time is ticking $$$$$$$$ buy out out will happen $$$$$$$ load load load $$$$$$$$$
      AMRN
      rjs1 rjs1 4 minutes ago
      Crossing the Tech Adoption Chasm

      In the fast-paced world of technology, bringing a new product to market is often a challenging endeavor. One of the main reasons many new product launches fail is the rush to target the mainstream market before adequately validating the technology wi
      LWLG
      nowwhat2 nowwhat2 4 minutes ago
      Sniffy sniffy underarms

      https://investorshub.advfn.com/uimage/uploads/2024/7/22/sqcgzsteez_crappy_chart.jpg
      XRPUSD
      Awl416 Awl416 4 minutes ago
      Its backs now. Been doing it quite a bit recently.

      Thank you though. Hope you made money today

      Cheers
      MIRA
      Bull_Dolphin Bull_Dolphin 4 minutes ago
      Got me a new shirt on order (same as Hulk Hogans at the RNC):

      https://lh7-us.googleusercontent.com/docsz/AD_4nXcOxjCIXDqfofhMk_SsO6YjapELdF9FXqSMer5rr2sa61W0ZZDusGfC8okk83zDIYEZJRcM0Eg5E6xzAjoys0oeWYJGlrYfYYTYw7MocA4kiVHBJKYbNZrLewX0RYMpLKDbmFkkKHE9ZzOUGtDMdTPScWfE?key=GHDTsJS1Ml4DnJi
      otc37 otc37 5 minutes ago
      Some people just cant see the forest from the trees. Longs and smart money know what they are holding here. I spent half my working life in the HVAC industry so i am holding with diamond hands on this play.
      VXIT
      janice shell janice shell 5 minutes ago
      Ohhhhh. Bummer.
      StockItOut StockItOut 5 minutes ago
      lol. Xeriant defaulted on Movychem in late 2022.
      So that's a year and a half of Xeriant solo Nexboard.
      Looks fake. Like an outright lie and scam.
      Duffys still drawing salary and independent contractor fees.
      Defudis drawing Xeriant independent contractor fees while busy wi
      XERI
      US-JUSTICE US-JUSTICE 5 minutes ago
      cowtown obviously works for humanigen and is the moderator. why he keeps posting about the lenzi and cheerleading about patents and this company even though it' has declared banktruptcy. either taran needs new investors if it decides to go 'public again' cowtown and humanigen selling hopium to spec
      CommodityCoverage CommodityCoverage 5 minutes ago
      Marking a significant milestone as it's the first exploration in five decades, Prismo Metals (PRIZ.c PMOMF) is set to commence a 5,000m drill program in Q3 at its Hot Breccia Copper Project where it has the potential to delineate a very large copper system, possibly akin to the nearby, monstrous Res
      PMOMF
      StayHumble StayHumble 5 minutes ago
      Power2 the P1ayers Huzzah!🟩🟩
      GME
      DewDiligence DewDiligence 6 minutes ago
      2Q24 results were not as bad as some investors expected, given the lower average price realization compared to prior quarters (#msg-174791870).
      CLF
      straightword straightword 6 minutes ago
      Remember when we were told that all of the big court dates and decisions would be in May?
      VPLM
      madras50 madras50 6 minutes ago
      mine shows 3.50/3.60
      MIRA
      MomsSpaghetti MomsSpaghetti 6 minutes ago
      This is about to reverse

      https://i.ibb.co/PW4s9gq/sc.png
      SWISF
      Lazarus Elite Lazarus Elite 7 minutes ago
      It's elementary my dear Watson. If you diamond hand this and don't sell a single share, they have to pay in blood for each share. How many shares do they have to break through?

      Nasrat has 350 million
      Insiders hold how many more million? 100 million?
      Now list ballpark sha
      ELTP
      Latenightmike57 Latenightmike57 7 minutes ago
      LMAO !! There’s always one that’s clueless
      You should be loading up then. LOL !!


      DO YOUR OWN DD !!
      SMME

      Your Recent History

      EU
      AELIS
      Aelis Farma
      NYSE
      OR
      Osisko Gold Royalties
      Delayed Upgrade Clock